Efficacy and safety of sofosbuvir and daclatasvir in treatment of kidney transplantation recipients with hepatitis C virus infection

AIM: To assess the efficacy and safety of sofosbuvir and daclatasvir regimens for kidney transplantation (KT) patients with hepatitis C virus (HCV) infection. METHODS: This study enrolled a prospective cohort of consecutive Chinese KT patients with HCV infection. They were given sofosbuvir combined...

Descripción completa

Detalles Bibliográficos
Autores principales: Xue, Yan, Zhang, Li-Xin, Wang, Lei, Li, Tao, Qu, Yun-Dong, Liu, Feng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2017
Materias:
Prospective Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583582/
https://www.ncbi.nlm.nih.gov/pubmed/28932089
http://dx.doi.org/10.3748/wjg.v23.i32.5969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583582/
https://www.ncbi.nlm.nih.gov/pubmed/28932089
http://dx.doi.org/10.3748/wjg.v23.i32.5969

Ejemplares similares